These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38439022)

  • 1. Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma.
    Xu Y; Hua J; Que H; Zeng T; Li Q; Deng J; Xie J
    BMC Cancer; 2024 Mar; 24(1):292. PubMed ID: 38439022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
    Jiang Z; Wang J; Dao C; Zhu M; Li Y; Liu F; Zhao Y; Li J; Yang Y; Pan Z
    Apoptosis; 2024 Jun; 29(5-6):681-692. PubMed ID: 38281281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
    Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
    Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC.
    Wang Y; Zhou J; Zhang N; Zhu Y; Zhong Y; Wang Z; Jin H; Wang X
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
    Gu Y; Huang Q; Wang Y; Wang H; Xiang Z; Xu Y; Wang X; Liu W; Wang A
    BMC Cancer; 2024 Apr; 24(1):420. PubMed ID: 38580922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging diverse cell-death related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
    Wu Z; Jin M; Xin P; Zhang H
    Front Immunol; 2023; 14():1293729. PubMed ID: 38146369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the role of immune-related PANoptosis lncRNA model in renal clear cell carcinoma based on RNA transcriptome and single-cell sequencing.
    Liu W; Qu C; Wang X
    Oncol Res; 2023; 31(4):543-567. PubMed ID: 37415739
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
    Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
    Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
    Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
    Front Immunol; 2022; 13():954440. PubMed ID: 36059510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
    Zhuang L; Sun Q; Huang S; Hu L; Chen Q
    Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma.
    Liu L; Jin H; Dong M; Tian J; Li H; Liu Q; Chen Y; Zou Z
    Apoptosis; 2022 Dec; 27(11-12):946-960. PubMed ID: 36028785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning-based on cytotoxic T lymphocyte evasion gene develops a novel signature to predict prognosis and immunotherapy responses for kidney renal clear cell carcinoma patients.
    Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
    Front Immunol; 2023; 14():1192428. PubMed ID: 37600786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
    Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
    Front Immunol; 2021; 12():657951. PubMed ID: 34531849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and experimental validation of PYCARD as a crucial PANoptosis-related gene for immune response and inflammation in COPD.
    Shi R; Liang R; Wang F; Wang L; Zidai W; Zhang J; Min L; Du X; Sun S; Xiao C; Li C; Liang X; Chen AF; Yang W
    Apoptosis; 2024 Apr; ():. PubMed ID: 38652339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy.
    Yi X; Li J; Zheng X; Xu H; Liao D; Zhang T; Wei Q; Li H; Peng J; Ai J
    Mol Ther Nucleic Acids; 2023 Sep; 33():376-390. PubMed ID: 37547288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer.
    Pan H; Pan J; Li P; Gao J
    Clin Immunol; 2022 May; 238():109019. PubMed ID: 35470064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.